Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy
Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy
复制标题
DOI：
10.1177/1098612x11429645
复制
发表时间：
2012-04-01
影响因子：
1.7
通讯作者：
Bennett, Peter F.
中科院分区：
文献类型：
--
作者：
Hambrook, Lydia E.;Bennett, Peter F.
这项回顾性研究旨在评估匹莫苯对患有非牛磺酸反应性扩张型心肌病（DCM）的猫的中位生存时间（MST）的影响。32只客户拥有的猫在收缩末期的左心室内部尺寸（LVID）>14 mm，缩短分数（FS）为非匹莫苯组的4倍（12天; 1至244天）。两组之间的生存率差异具有统计学意义（P=0.048）。体温过低和FS
This retrospective study was designed to assess the effect of pimobendan on the median survival time (MST) of cats with non-taurine responsive dilated cardiomyopathy (DCM). Thirty-two client-owned cats with a left ventricular internal dimension at end systole (LVIDs) >14 mm, a fractional shortening (FS) 502 days) was four times that of the non-pimobendan group (12 days; 1 to 244 days). The difference in survival between the two groups was statistically significant (P=0.048). Hypothermia and FS